Editorial: Intracoronary Brachytherapy for In-Stent Restenosis: Not Bad in the Sprint, But Fails in the Marathon
Cardiovasc Revasc Med
.
2023 Sep:54:5-6.
doi: 10.1016/j.carrev.2023.05.019.
Epub 2023 May 29.
Author
Tim A Fischell
1
Affiliation
1
Michigan State University, United States of America; Western Michigan University, United States of America; Borgess Heart Institute, 1521 Gull Road, Kalamazoo, MI 49008, United States of America. Electronic address: tafisc@gmail.com.
PMID:
37271595
DOI:
10.1016/j.carrev.2023.05.019
No abstract available
Publication types
Editorial
Comment
MeSH terms
Brachytherapy* / adverse effects
Constriction, Pathologic
Coronary Restenosis* / diagnostic imaging
Coronary Restenosis* / etiology
Coronary Restenosis* / radiotherapy
Humans
Stents